Ramoji Kosuru | Pharmacology | Best Researcher Award

Mr. Ramoji Kosuru | Pharmacology | Best Researcher Award

Research Scientist-I at Versiti Blood Research Institute, United States.

Dr. Ramoji Kosuru is an accomplished cell and vascular biologist ๐Ÿ‘จโ€๐Ÿ”ฌ currently serving as a Postdoctoral Fellow and Research Scientist-I at the Versiti Blood Research Institute in Milwaukee, USA ๐Ÿงฌ๐Ÿ‡บ๐Ÿ‡ธ. With a deep focus on cardiovascular and metabolic disorders, Dr. Kosuru has made pioneering contributions in endothelial Rap1 signaling, nitric oxide regulation, and diabetic cardiomyopathy ๐Ÿ’“. His research has been featured in high-impact journals like ATVB, IJMS, Angiogenesis, and Frontiers in Pharmacology ๐Ÿ“š. Beyond bench science, he also serves as an academic editor for prestigious journals, reflecting his leadership in the field ๐Ÿ–‹๏ธ. Known for his innovation, precision, and collaboration, Dr. Kosuru blends pharmacological insight with molecular biology expertise to address complex cardiovascular challenges ๐Ÿ”โค๏ธ. His global collaborations and fellowships signify a rising scientific star with strong translational potential ๐ŸŒโœจ.

Professional Profile:

Scopus

ORCID

Google Scholar

Suitability For Best Researcher Award – Mr. Ramoji Kosuru

Dr. Ramoji Kosuru is exceptionally suitable for the Best Researcher Award due to his sustained and innovative contributions in cardiovascular biology, particularly in the molecular mechanisms governing endothelial function, nitric oxide regulation, and diabetic cardiomyopathy. His work spans the intersection of pharmacology and cell signaling, blending foundational science with translational potential. Currently positioned as a Postdoctoral Fellow and Research Scientist-I at the Versiti Blood Research Institute (USA), Dr. Kosuru has built an internationally recognized profile supported by over 35 peer-reviewed publications, editorial responsibilities, and advanced technical skills.

๐ŸŽ“ Education

Dr. Ramoji Kosuru began his academic journey with a Bachelorโ€™s in Pharmacy (B.Pharm.) from Acharya Nagarjuna University, India ๐Ÿ‡ฎ๐Ÿ‡ณ. He advanced to earn a Masterโ€™s in Pharmacology (M.Pharm.) from Andhra University ๐Ÿ“˜. His thirst for scientific discovery led him to the prestigious Indian Institute of Technology (BHU), Varanasi, where he completed his Ph.D. in 2018, focusing on Diabetic Cardiomyopathy ๐Ÿ”ฌ๐Ÿ’‰. To pursue advanced research, he moved to the United States, where he undertook Postdoctoral training in Vascular Signaling at Versiti Blood Research Institute, Wisconsin, and currently holds a Research Scientist-I position ๐ŸŽ“๐Ÿง . His academic path highlights an exceptional blend of pharmacy, pharmacology, and cutting-edge cardiovascular research ๐Ÿงช๐Ÿ’–.

๐Ÿ’ผ Experience

Dr. Kosuruโ€™s professional journey began as a Graduate Student at IIT-BHU (2012โ€“2018) where he developed natural product therapies for diabetic heart disease ๐ŸŒฟโค๏ธ. Post-Ph.D., he joined Versiti Blood Research Institute in Wisconsin as a Postdoctoral Fellow (2018โ€“Present), later progressing to Research Scientist-I ๐Ÿ‘จโ€๐Ÿ”ฌ. His ongoing research explores the role of Rap1 GTPases in endothelial function and nitric oxide signaling ๐Ÿงฌ๐Ÿฉธ. Heโ€™s contributed to over 35 publications, several as a lead author, and is well-versed in in vitro, in vivo, and molecular techniques ๐Ÿงซ๐Ÿงช. His active participation in interdisciplinary collaborations and mentoring roles demonstrates a growing leadership trajectory in biomedical sciences ๐Ÿง ๐Ÿ’ผ.

๐Ÿ“ˆ Professional Development

Dr. Kosuru has continually enhanced his professional capabilities through cutting-edge research, mentorship, and editorial duties ๐Ÿ“š๐Ÿ’ก. He has mastered advanced techniques like endothelial calcium imaging, NO assays, and gene silencing, contributing novel insights into cardiovascular pathophysiology ๐Ÿ”ฌโค๏ธ. His postdoctoral training under Dr. Chrzanowska has equipped him with grant writing, international conference presentations, and collaboration-building skills ๐ŸŒ๐Ÿ“Š. He also serves as an Academic Editor for Oxidative Medicine and Cellular Longevity and BioMed Research International, demonstrating his growing authority in the field โœ๏ธ๐Ÿง . As a member of ASCB and NAVBO, Dr. Kosuru remains connected to leading scientific networks. With a proven record of publishing, reviewing, and mentoring, he exemplifies a well-rounded, impactful researcher dedicated to continuous growth and contribution ๐Ÿ”„๐ŸŒŸ.

๐Ÿงช Research Focus

Dr. Kosuruโ€™s research primarily focuses on Cardiovascular Biology, with particular emphasis on endothelial signaling, vascular homeostasis, diabetic cardiomyopathy, and vascular immunosuppression ๐Ÿซ€๐Ÿงฌ. His work on Rap1 isoforms (Rap1A & Rap1B) has revealed novel regulatory pathways involving calcium signaling and nitric oxide synthesis, shedding light on mechanisms underlying heart failure, inflammation, and vascular dysfunction ๐Ÿ”โš ๏ธ. Additionally, his research bridges into metabolic diseases such as diabetes, using natural products to modulate oxidative stress and apoptosis ๐ŸŒฟโšก. Recently, heโ€™s contributed to uncovering vascular immune evasion mechanisms in cancer, offering potential therapeutic targets in immuno-oncology ๐Ÿ’‰๐ŸŽฏ. Dr. Kosuruโ€™s approach integrates cell biology, pharmacology, and translational medicine, making his work relevant for cardiovascular therapy, metabolic health, and immune modulation in vascular biology ๐Ÿš‘๐Ÿง .

๐Ÿง  Research Skills

Dr. Kosuru possesses a rich repertoire of technical skills across molecular pharmacology, vascular biology, and cell signaling ๐Ÿงฌ๐Ÿ”ฌ. He specializes in endothelial function assays, including calcium imaging, NO measurement, and store-operated calcium entry (SOCE) modulation ๐Ÿ”๐Ÿงช. His expertise extends to Western blotting, ELISA, qPCR, animal models of diabetes and ischemia-reperfusion injury, and natural compound-based drug discovery ๐ŸŒฟ๐Ÿ’Š. Dr. Kosuru also brings solid experience in nanocarrier formulation, pharmacokinetics, and translational preclinical models, making him adept at bridging basic research and therapeutic application ๐Ÿš€โš—๏ธ. Heโ€™s proficient in scientific communication, grant writing, manuscript preparation, and collaborative research leadership ๐Ÿง โœ๏ธ. His integrative and multidisciplinary skill set is tailored for innovation in cardiovascular, metabolic, and inflammatory disease research ๐Ÿ”ง๐Ÿ’–.

๐Ÿ† Awards & Honors

Dr. Ramoji Kosuru has earned notable accolades throughout his academic and research journey ๐Ÿ…๐ŸŽ“. He received the Richard S. Gallagher Fellowship from Versiti Blood Research Institute in 2021 ๐ŸŒŸ, recognizing his excellence in cardiovascular research. Earlier, he was honored with the Prof. Govind Achari Award by the Indian Pharmacological Society in 2017 for the best oral presentation ๐Ÿ—ฃ๏ธ๐Ÿ†. He has also held prestigious scholarships like the UGC Fellowship (2006โ€“2008) and the Institute Teaching Assistantship from MHRD during his Ph.D. years ๐Ÿ“˜๐ŸŽ–๏ธ. These honors underline his academic rigor, innovation, and growing reputation as a leader in biomedical sciences ๐Ÿ“š๐Ÿ’ผ.

Publication Top Notes

1. Endothelial Rap1B mediates T-cell exclusion to promote tumor growth: a novel mechanism underlying vascular immunosuppression

Authors: GP Sharma, R Kosuru, S Lakshmikanthan, et al.
Journal: Angiogenesis, 2023, 26(2): 265โ€“278
Citations: 7
Summary:
This study identifies a new role for endothelial Rap1B in suppressing immune cell infiltration into tumors, thereby facilitating tumor growth. It uncovers a novel mechanism of vascular immunosuppression.

2. Natural products targeting oxidative stress and cell death: Treatment potential in metabolic and cardiovascular diseases

Authors: R Kosuru, Y Cai, V Tiwari
Journal: Frontiers in Pharmacology, 2023, 14: 1141878
Citations: 5
Summary:
This review explores various natural compounds that influence oxidative stress and cell death, evaluating their therapeutic prospects for treating metabolic and cardiovascular diseases.

3. Role of AMPK in Myocardial Ischemiaโ€Reperfusion Injuryโ€Induced Cell Death in the Presence and Absence of Diabetes

Authors: N Kandula, S Kumar, VKK Mandlem, et al.
Journal: Oxidative Medicine and Cellular Longevity, 2022, Article ID: 7346699
Citations: 13
Summary:
The paper investigates how AMPK functions during myocardial injury due to ischemia-reperfusion, comparing effects in diabetic and non-diabetic conditions to understand its role in cardiac cell survival.

4. Formulation, Optimization, and In Vitro Characterization of Dasatinib Loaded Polymeric Nanocarriers to Extend the Release of the Model Drug

Authors: RK Sandeep Kumar Reddy Adena, Kasi Viswanadh Matte
Journal: International Journal of Applied Pharmaceutics, 2021, 13(5): 318โ€“330
Citations: 4
Summary:
This research focuses on designing and optimizing polymeric nanoparticles for controlled release of Dasatinib, aiming to enhance its therapeutic profile.

5. Distinct signaling functions of Rap1 isoforms in NO release from endothelium

Authors: R Kosuru, B Singh, S Lakshmikanthan, et al.
Journal: Frontiers in Cell and Developmental Biology, 2021, 9: 687598
Citations: 9
Summary:
The study examines the individual roles of Rap1A and Rap1B proteins in regulating nitric oxide production from endothelial cells, revealing distinct signaling pathways.

6. Endothelial Rap1 restricts inflammatory signaling to protect from the progression of atherosclerosis

Authors: B Singh, R Kosuru, S Lakshmikanthan, et al.
Journal: Arteriosclerosis, Thrombosis, and Vascular Biology, 2021, 41(2): 638โ€“650
Citations: 49
Summary:
This article highlights the protective function of endothelial Rap1 in vascular inflammation and atherosclerosis, demonstrating its potential as a therapeutic target.

7. Preclinical evidence of the therapeutic role of Pterostilbene: focus on the mitochondria

Authors: R Kosuru, MR Vijayakumar, S Singh
Book Chapter: Mitochondrial Physiology and Vegetal Molecules, 2021, Pages 301โ€“315
Citations: 2
Summary:
This chapter reviews the mitochondrial benefits of pterostilbene based on preclinical evidence, discussing its potential utility in disease prevention and health promotion.

8. Adiponectin Facilitates Postconditioning Cardioprotection through Both AMPK-Dependent Nuclear and AMPK-Independent Mitochondrial STAT3 Activation

Authors: ZX Qiqi Zhu, Haobo Li, Xiang Xie, Xiaozhen Chen, Ramoji Kosuru, et al.
Journal: Oxidative Medicine and Cellular Longevity, 2020
Citations: 20
Summary:
The paper studies adiponectinโ€™s cardioprotective effects post-ischemia by activating both AMPK-dependent and independent signaling, emphasizing its dual mechanism of action.

๐Ÿ Conclusion

Dr. Ramoji Kosuru stands out as a transformative figure in biomedical research, particularly in vascular biology and metabolic disease. His trajectory from India to a leading U.S. research institute, combined with novel mechanistic discoveries, strong publication record, editorial leadership, and technical versatility, exemplifies excellence, innovation, and global relevance. He not only meets but exceeds the standards typically expected for the Best Researcher Awardโ€”making him a compelling and well-qualified nominee.

Muneeb Ullah | Pharmaceutics | Best Researcher Award

Muneeb Ullah | Pharmaceutics | Best Researcher Award

PhD at Pusan National University, Busan South Korea, South Korea.

Muneeb Ullah is an emerging pharmaceutical scientist with a specialization in pharmaceutical nanotechnology. His passion for research, particularly in drug delivery systems and nanotechnology, is evident through his MPhil work on Beclomethasone Dipropionate Loaded Polymeric Nanoparticles. With extensive laboratory experience and a drive to contribute to the field, Muneeb has received recognition for his academic excellence and teaching. His ambition is to further advance his research in nanotechnology, utilizing his strong technical skills to innovate and improve therapeutic techniques.

Profile๐Ÿ‘ค

Scopus

Education ๐ŸŽ“

Muneeb Ullah holds an MPhil in Pharmaceutical Sciences with a focus on Pharmaceutical Nanotechnology from the Department of Pharmacy at Kohat University of Science and Technology (KUST), Pakistan. His thesis centered on the development of polymeric nanoparticles, showcasing his expertise in advanced drug delivery methods. He completed his BS in Pharmacy (Pharm-D) from the same institution, consistently achieving first-division academic scores. His foundational education includes F.Sc (Pre-Medical) and Matriculation from top institutions in KPK, Pakistan, further highlighting his academic commitment.

Experience๐Ÿ’ผ

Muneeb has served as a Visiting Faculty Member at Billitong Higher Secondary School in Kohat and as a Research Assistant at the National University of Medical Sciences (NUMS) in Islamabad. His experience extends beyond academia, involving significant laboratory work in pharmaceutical research. His practical skills range from nanoparticle preparation and size analysis to conducting antibacterial and antibiofilm activity studies. These roles have enabled him to develop both his teaching and research abilities, making him a well-rounded candidate for future research and educational positions.

Research Interests ๐Ÿ”ฌ

Muneeb Ullahโ€™s research interests lie in pharmaceutical nanotechnology, particularly in the development of novel drug delivery systems. His MPhil thesis on Beclomethasone Dipropionate-loaded nanoparticles reflects his focus on creating more effective therapeutic interventions. He is also interested in biochemistry, pharmacology, and the advancement of natural plant-based pharmaceutical products. His aim is to explore new materials and techniques for improving drug efficacy and patient outcomes.

Awards and Honors ๐Ÿ†

Muneeb has received numerous awards for his academic and professional achievements. He was a recipient of the Higher Education Commission (HEC) Indigenous Scholarship for his BS in Pharmacy and won the Prime Minister Laptop Scheme Award in 2019. Additionally, he was honored with the Best Teacher Award at Billitong Higher Secondary School in 2020, recognizing his commitment to education alongside his research pursuits.

Conclusion ๐Ÿ”šย 

Muneeb Ullahโ€™s strong academic background, technical expertise in pharmaceutical nanotechnology, and achievements such as scholarships and awards position him as a competitive candidate for the Best Researcher Award. His blend of teaching, research, and laboratory experience reflects his commitment to the field of pharmaceutical sciences. With continued research output, international collaborations, and further honing of his communication skills, he has the potential to make significant contributions to pharmaceutical research, warranting recognition at a higher level.

Publications Top Notesย ๐Ÿ“š

Microbiome Miracles and Their Pioneering Advances and Future Frontiers in Cardiovascular Disease
Safdar, M., Ullah, M., Hamayun, S., Mustopa, A.Z., Hasan, N.
Current Problems in Cardiology, 2024, 49(9), 102686.

Development of Clindamycin-Releasing Polyvinyl Alcohol Hydrogel with Self-Healing Property for the Effective Treatment of Biofilm-Infected Wounds
Alifah, N., Palungan, J., Ardayanti, K., Yoo, J.-W., Hasan, N.
Gels, 2024, 10(7), 482.

3D Printing Technology and Its Revolutionary Role in Stent Implementation in Cardiovascular Disease
Khan, M.A., Khan, N., Ullah, M., Naeem, M., Hasan, N.
Current Problems in Cardiology, 2024, 49(6), 102568.

Recent Advancements in Nanotechnology-Based Drug Delivery for the Management of Cardiovascular Disease
Ullah, A., Ullah, M., Lim, S.I.
Current Problems in Cardiology, 2024, 49(4), 102396.

Nanotherapeutic Approaches for Transdermal Drug Delivery Systems and Their Biomedical Applications
Khan, S.U., Ullah, M., Saeed, S., Khan, M.A., Lu, K.
European Polymer Journal, 2024, 207, 112819.

Single-cell RNA Sequencing (scRNA-seq): Advances and Challenges for Cardiovascular Diseases (CVDs)
Khan, S.U., Huang, Y., Ali, H., Ullah, M., Lu, K.
Current Problems in Cardiology, 2024, 49(2), 102202.

A Review of Recent Advances in Nanotechnology for the Delivery of Therapeutics in Wound Healing
Ullah, A., Ullah, M., Lee, G.-J., Lim, S.I.
Journal of Pharmaceutical Investigation, 2024 (In Press).

Genomic Insights into Heart Health: Exploring the Genetic Basis of Cardiovascular Disease
Safdar, M., Ullah, M., Wahab, A., Awan, U.A., Naeem, M.
Current Problems in Cardiology, 2024, 49(1), 102182.

Shaping the Future of Cardiovascular Disease by 3D Printing Applications in Stent Technology and Its Clinical Outcomes
Ullah, M., Bibi, A., Wahab, A., Saeed, S., Hussain, T.
Current Problems in Cardiology, 2024, 49(1), 102039.